Literature DB >> 11760156

Vancomycin-resistant enterococci in neonates.

A Yüce1, M Karaman, Z Gülay, N Yulug.   

Abstract

Fecal-oral transmission of vancomycin-resistant strains of Enterococci (VRE), which colonize the human gastrointestinal tract, has led to nosocomial epidemics in recent years. The aim of this study was to establish the incidence and associated factors of fecal colonization with VRE in neonates. In our hospital 110 rectal swab specimens collected in the neonatal intensive care unit (NICU) were examined for VRE. For comparison, rectal swabs collected from 42 healthy neonates on the obstetrics ward were also analyzed. Of the NICU patients, 8 had VRE MICs of 8-64 microg/ml for vancomycin and 2-32 microg/ml for teicoplanin, whereas none of the healthy newborns, had VRE (p < 0.05). All patients positive for VRE had factors known to be associated with VRE carriage, such as low birth weight or long-term antibiotic therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11760156     DOI: 10.1080/00365540110027295

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

1.  First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey.

Authors:  F B Comert; C Kulah; E Aktas; N Ozlu; G Celebi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

2.  Characterization of a vancomycin-resistant Enterococcus faecium outbreak caused by 2 genetically different clones at a neonatal intensive care unit.

Authors:  Wee Gyo Lee; Sun Hyun Ahn; Min Kwon Jung; Hye Young Jin; Il Joong Park
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

3.  Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit.

Authors:  Rajesh Amberpet; Sujatha Sistla; Subhash Chandra Parija; Ramachandran Rameshkumar
Journal:  J Lab Physicians       Date:  2018 Jan-Mar

4.  Mother-to-Neonate Transmission of Antibiotic-Resistant Bacteria: A Cross-Sectional Study.

Authors:  Lital Ashtamkar Matok; Maya Azrad; Tamar Leshem; Anan Abuzahya; Thanaa Khamaisi; Tatiana Smolkin; Avi Peretz
Journal:  Microorganisms       Date:  2021-06-08

5.  An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

Authors:  Louise F Hill; Mark A Turner; Irja Lutsar; Paul T Heath; Pollyanna Hardy; Louise Linsell; Evelyne Jacqz-Aigrain; Emmanuel Roilides; Mike Sharland
Journal:  Trials       Date:  2020-04-15       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.